Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

2.
3.

Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway.

Maes M, Rief W.

Psychiatry Res. 2012 Apr 30;196(2-3):243-9. doi: 10.1016/j.psychres.2011.09.029. Epub 2012 Feb 24.

PMID:
22364930
5.

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.

Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.

Mol Psychiatry. 2005 Jun;10(6):538-44.

PMID:
15494706
7.

Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.

Schefold JC, Zeden JP, Pschowski R, Hammoud B, Fotopoulou C, Hasper D, Fusch G, Von Haehling S, Volk HD, Meisel C, Schütt C, Reinke P.

Scand J Infect Dis. 2010 Mar;42(3):164-71. doi: 10.3109/00365540903405768.

PMID:
19958238
8.

Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.

Kanth VR, Lavanya K, Srinivas J, Raju TN.

Curr Eye Res. 2009 Apr;34(4):274-81. doi: 10.1080/02713680902725954. Erratum in: Curr Eye Res. 2009 Jun;34(6):516. Raju, Turlapati Naga [added].

PMID:
19373575
9.

A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.

Baranyi A, Meinitzer A, Stepan A, Putz-Bankuti C, Breitenecker RJ, Stauber R, Kapfhammer HP, Rothenhäusler HB.

Psychother Psychosom. 2013;82(5):332-40. doi: 10.1159/000348587. Epub 2013 Aug 9.

PMID:
23942342
10.

Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.

Anderson G, Maes M, Berk M.

Adv Protein Chem Struct Biol. 2012;88:27-48. doi: 10.1016/B978-0-12-398314-5.00002-7. Review.

PMID:
22814705
11.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.

Nephrol Dial Transplant. 2009 Jun;24(6):1901-8. doi: 10.1093/ndt/gfn739. Epub 2009 Jan 20.

12.

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH.

Int J Biochem Cell Biol. 2009 Mar;41(3):467-71. doi: 10.1016/j.biocel.2008.01.005. Epub 2008 Jan 11. Review.

PMID:
18282734
13.

Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: evidence from the Young Finns study.

Elovainio M, Hurme M, Jokela M, Pulkki-Råback L, Kivimäki M, Hintsanen M, Hintsa T, Lehtimäki T, Viikari J, Raitakari OT, Keltikangas-Järvinen L.

J Affect Disord. 2011 Oct;133(3):611-4. doi: 10.1016/j.jad.2011.04.025. Epub 2011 May 19.

PMID:
21600662
14.
15.

Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.

Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctôt KL.

Psychoneuroendocrinology. 2009 Nov;34(10):1560-6. doi: 10.1016/j.psyneuen.2009.05.019. Epub 2009 Jun 21.

PMID:
19540675
16.

Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.

Munipally PK, Agraharm SG, Valavala VK, Gundae S, Turlapati NR.

Arch Physiol Biochem. 2011 Dec;117(5):254-8. doi: 10.3109/13813455.2011.623705. Epub 2011 Oct 29.

PMID:
22034910
17.
18.

Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.

Barry S, Clarke G, Scully P, Dinan TG.

J Psychopharmacol. 2009 May;23(3):287-94. doi: 10.1177/0269881108089583. Epub 2008 Jun 18.

PMID:
18562404
19.

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.

Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG.

BMC Gastroenterol. 2009 Jan 20;9:6. doi: 10.1186/1471-230X-9-6.

20.

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Saito K, Markey SP, Heyes MP.

Neuroscience. 1992 Nov;51(1):25-39.

PMID:
1465184
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk